Abstract
The aim of the present study was to investigate the efficacy of probiotic yoghurt Lactobacillus rhamnosus GG (LGG) in the treatment of Irritable bowel syndrome (IBS). Eighty-three IBS patients yielded data to be analysed from this 9-week, placebo-controlled, double-blind and randomized trial. The patients consumed either a LGG-containing probiotic yoghurt (treatment group; n = 44) or a placebo (n = 39) twice daily for 6 weeks. The results indicate that this probiotic yoghurt was effective in alleviating some IBS symptoms and resulted in slight changes in certain gut microbiota. Probiotic yoghurt may represent a treatment for some gastrointestinal disorders.
Original language | English |
---|---|
Pages (from-to) | 243-255 |
Number of pages | 13 |
Journal | International Journal of Dairy Technology |
Volume | 66 |
Issue number | 2 |
DOIs | |
Publication status | Published - 2013 May |
Keywords
- DGGE
- Faecal microbiota
- IBS symptom
- Irritable bowel syndrome
- Probiotic yoghurt
ASJC Scopus subject areas
- Food Science
- Bioengineering
- Process Chemistry and Technology